New Enterprise Associates (NEA) led the equity funding, and additional investments were received from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures and Redpoint, alongside several new institutional investors, including funds and accounts managed by affiliates of BlackRock, Inc. Hercules Capital led the debt financing.

Strive Health is the nation's leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of AI technology, care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 145,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST.